These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7591966)

  • 1. Inostamycin, an inhibitor of P-glycoprotein function, interacts specifically with phosphatidylethanolamine.
    Kawada M; Umezawa K
    Jpn J Cancer Res; 1995 Sep; 86(9):873-8. PubMed ID: 7591966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-lasting accumulation of vinblastine in inostamycin-treated multidrug-resistant KB cells.
    Kawada M; Umezawa K
    Jpn J Cancer Res; 1991 Oct; 82(10):1160-4. PubMed ID: 1955381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells.
    Tamai I; Safa AR
    J Biol Chem; 1991 Sep; 266(25):16796-800. PubMed ID: 1679434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesicles.
    Horio M; Lovelace E; Pastan I; Gottesman MM
    Biochim Biophys Acta; 1991 Jan; 1061(1):106-10. PubMed ID: 1671642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the azidopine and vinblastine binding site of P-glycoprotein.
    Bruggemann EP; Currier SJ; Gottesman MM; Pastan I
    J Biol Chem; 1992 Oct; 267(29):21020-6. PubMed ID: 1356986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-glycoprotein substrates and antagonists cluster into two distinct groups.
    Scala S; Akhmed N; Rao US; Paull K; Lan LB; Dickstein B; Lee JS; Elgemeie GH; Stein WD; Bates SE
    Mol Pharmacol; 1997 Jun; 51(6):1024-33. PubMed ID: 9187269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents.
    Pascaud C; Garrigos M; Orlowski S
    Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):351-8. PubMed ID: 9657975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric regulation of [3H]vinblastine binding to P-glycoprotein of MCF-7 ADR cells by dexniguldipine.
    Ferry DR; Malkhandi PJ; Russell MA; Kerr DJ
    Biochem Pharmacol; 1995 Jun; 49(12):1851-61. PubMed ID: 7598747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-glucocorticoid steroid analogues (21-aminosteroids) sensitize multidrug resistant cells to vinblastine.
    Abraham I; Wolf CL; Sampson KE
    Cancer Chemother Pharmacol; 1993; 32(2):116-22. PubMed ID: 8097968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of the 1,4-dihydropyridine drug acceptor of P-glycoprotein to a cytoplasmic domain using a permanently charged derivative N-methyl dexniguldipine.
    Ferry D; Boer R; Callaghan R; Ulrich WR
    Int J Clin Pharmacol Ther; 2000 Mar; 38(3):130-40. PubMed ID: 10739116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of P-glycoprotein-dependent multidrug resistance by an isoquinolinesulfonamide compound H-87 in rat ascites hepatoma AH66 cells.
    Nakamura S; Minamino T; Nomura M; Wakusawa S; Miyamoto K; Hidaka H
    Biol Pharm Bull; 1996 Jun; 19(6):886-9. PubMed ID: 8799494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two different regions of P-glycoprotein [corrected] are photoaffinity-labeled by azidopine.
    Bruggemann EP; Germann UA; Gottesman MM; Pastan I
    J Biol Chem; 1989 Sep; 264(26):15483-8. PubMed ID: 2475500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celastraceae sesquiterpenes as a new class of modulators that bind specifically to human P-glycoprotein and reverse cellular multidrug resistance.
    Muñoz-Martínez F; Lu P; Cortés-Selva F; Pérez-Victoria JM; Jiménez IA; Ravelo AG; Sharom FJ; Gamarro F; Castanys S
    Cancer Res; 2004 Oct; 64(19):7130-8. PubMed ID: 15466210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulators of the multidrug-transporter, P-glycoprotein, exist in the human plasma.
    Ichikawa M; Yoshimura A; Furukawa T; Sumizawa T; Akiyama S
    Biochem Biophys Res Commun; 1990 Jan; 166(1):74-80. PubMed ID: 1967939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg(3).
    Kim SW; Kwon HY; Chi DW; Shim JH; Park JD; Lee YH; Pyo S; Rhee DK
    Biochem Pharmacol; 2003 Jan; 65(1):75-82. PubMed ID: 12473381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexniguldipine-HCl is a potent allosteric inhibitor of [3H]vinblastine binding to P-glycoprotein of CCRF ADR 5000 cells.
    Malkhandi J; Ferry DR; Boer R; Gekeler V; Ise W; Kerr DJ
    Eur J Pharmacol; 1994 Dec; 288(1):105-14. PubMed ID: 7705462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of drug accumulation by andrastin A produced by Penicillium sp. FO-3929 in vincristine-resistant KB cells.
    Rho MC; Toyoshima M; Hayashi M; Uchida R; Shiomi K; Komiyama K; Omura S
    J Antibiot (Tokyo); 1998 Jan; 51(1):68-72. PubMed ID: 9531989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoplasmic orientation and two-domain structure of the multidrug transporter, P-glycoprotein, demonstrated with sequence-specific antibodies.
    Yoshimura A; Kuwazuru Y; Sumizawa T; Ichikawa M; Ikeda S; Uda T; Akiyama S
    J Biol Chem; 1989 Sep; 264(27):16282-91. PubMed ID: 2476441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different effects of FK317 on multidrug-resistant tumor in vivo and in vitro.
    Naoe Y; Inami M; Takagaki S; Matsumoto S; Kawamura I; Nishigaki F; Tsujimoto S; Manda T; Shimomura K
    Jpn J Cancer Res; 1998 Oct; 89(10):1047-54. PubMed ID: 9849584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Function of P-glycoprotein expressed in placenta and mole.
    Nakamura Y; Ikeda S; Furukawa T; Sumizawa T; Tani A; Akiyama S; Nagata Y
    Biochem Biophys Res Commun; 1997 Jun; 235(3):849-53. PubMed ID: 9207250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.